|
| |
Pfizer, Inc.
| Headquarters location: 235 East 42nd Street New York, NY 10017 |  | Tel. 212 573-2323 Job offers, investor relations: www.pfizer.com Stock:  |
|
| shareholder | country % source |
|
| subsidiary | country % source |
|
|
name  items photo compare the prices |
Shop local, ethical and at the best price on Ethishop ! |
|
|
« ETHICAL » RATING OF PFIZER
, group
and subsidiaries
[click on the images below or on help for more information] |
| Human: 1 violation(s) of fundamental human rights |
| Job: 13% of company's jobs cut since 1998 |
| Environment: 5 major pollution(s) |
| Delinquency: 6 act(s) of financial or trade delinquency |
| Tax haven, secret bank account, shell companies: operates in 16 offshore financial center(s) |
| Sales: more than 48 billion(s) dollars/euros in annual sales |
| Net profit: more than 61 billion(s) dollars/euros in cumulated net profit since 1998 |
| Top management: earns 779 times the median income in the United States (32000 US$/year) |
| Influence: 21 act(s) of direct corruption or lobbying |
| Advertising & marketing: 10 dubious practice(s) |
|
|
Relevance: business & market share |
year | business source |
| 2006 | Pfizer manufactures 8,2% of the drugs consumed in the world, largest world maker. | Les Echos  |
| 2005 | World's largest pharmaceutical company. | Les Echos |
| 2004 | Pfizer sells 26% of the tobacco substitutes bought in France. | Les Echos |
| 2004 | In 2004, five drugs (Lipitor, Norvasc, Zoloft, Celebrex, Neurontin) make 47% of the company's sales et more than 2 billion US$ each. 10 drugs (Lipitor, Norvasc, Zoloft, Celebrex, Neurontin, Zithromax, Viagra, Zyrtec, Bextra, Xalatan) make 61% of its sales and more than 1 billion US$ each. |  |
| 2003 | Pfizer produces 6% of the drugs bought in Japan | Les Echos |
|
World locations & Manufacturing |
| year name | photo position; compensation source |
| 1998Steere Jr, |  Chief Executive Officer; salary: 3.96 million US$; stock-options: 21.01 million US$; |
|
| year | dubious practice : image source |
| 2007 | Disinformation: In early September, "major newspapers reported the alarming news that suicides among young people were on the rise because of a precipitous drop in the use of antidepressants," writes Alison Bass. The academic study the news articles were based on concluded that new safety warnings for young people using antidepressant drugs had discouraged doctors from writing prescriptions for depressed youths. But there's a hole in that argument: "while there was indeed an upturn in suicide rates among youths ... the number of prescriptions for antidepressants in the same age group remained basically unchanged." Bass points out that the pharmaceutical companies that make antidepressants might "benefit from the latest alarm about an apparent upturn in youth suicide rates. ... These companies have an enormous stake in reversing the current FDA warnings." Pfizer, which makes the antidepressant Zoloft, did provide $30,000 for the academic study, and the study's lead authors have ties to Pfizer, GlaxoSmithKline and Wyeth Pharmaceuticals. "This isn't the first time that suicide rates have been trotted out as a public relations weapon," Bass adds. "Proponents of psychotropic drugs have long argued that suicide rates ... fell after" such drugs were introduced, though the decline began well before the drugs were widely prescribed.: | Boston Glo. |
| 2006 | Disinformation: Pfizer broadcasted a video news release (VNR), a fake TV news, on cable channel KPIX-5, without disclosure.: | PR Watch |
| 2006 | Biopiracy - Appropriation of public knowledge: Pfizer sues the Philippines to prevent it from producing a generic version of its drug, in spite of the international authorization of the agreements on the intellectual property (TRIPS).: | AFP |
| 2006 | Disinformation: Pfizer hired C&W PR group "for general representation
and issues concerning Medicare/Medicaid and pharmaceutical research & development." The 11-person team assigned to the account includes former Minnesota Republican Congressman, Vin Weber. Weber is also Chairman of the National Endowment for Democracy and a board member of both the Aspen Institute and Citizens Against Government Waste. He was also involved with the neo-conservative network, the Project for a New American Century. In mid-June two men announced they were suing Pfizer, alleging serious side effects from the anti-cholesterol drug Lipitor.: public relations: C | PR Watch |
| 2005 | Arguable partnership: Sharing the Care: "Pfizer donates its most advanced medicines to low-income, uninsured patients through a network of more than 380 federally-qualified health centers": value: Health partner; | |
| 2005 | Arguable partnership: Partnership for Prescription Assistance with the American Academy of Family Physicians, American Academy of
Physician Assistants, American College of Emergency Physicians, NAACP, National Alliance for Hispanic Health, National Alliance for the Mentally Ill, National Association of Chain Drug Stores, National Medical Association, National Urban League, United Way of America.: value: Health; | |
| 2005 | Disinformation: Sponsor of the Business for Social Responsibility's 2005 conference.: | PR Watch |
| 2005 | Arguable partnership: Connection to Care: "medicines reach patients in need through individual physicians' offices": value: Health partner; | |
| 2004 | Disinformation: In December 2004 a report linked high doses of Celebrex, a member of the class of drugs referred to as Cox-2 inhibitors, to an increased risk of heart attacks. The co-managing director of the WPP Group's health and medical practice, Sherry Pudloski, told O'Dwyer's PR Daily that they still had the account but declined to talk about what they did for Pfizer.: | Sourcewatc. |
| 2004 | In November 2004 Ogilvy Public Relations Worldwide - a part of the WPP Group - took over the accounts for both of Pfizer's Celebrex and Bextra pain medications.: | Sourcewatc. |
| 2004 | Arguable partnership: Don pour les victimes du tsunami: 10000000 de dollars: value: Humanitaire; | |
|
|
| year | employees <> | social impact : country source |
| 2008 | -275 | Internal restructuring: Pfizer cuts 275 jobs from its manufacturing operations in Kalamazoo County, as part of "ongoing efforts to remain globally competitive". "We're restructuring many of our support staff, supervisory and operational functions in Kalamazoo manufacturing," the company spokesman said.: United States of America | |
| 2008 | -500 | Internal restructuring: Pfizer cuts half of its manpower of medical representatives to physicians in France (- 400 jobs), and a quarter of its medical representatives to the hospitals and specialist physicians. According to a trade union, this plan aims at improving the net margin, the ratio net profit on sales, currently at 28% to 35% in 2010.: France | Les Echos |
| 2008 | -219 | Relocation: Pfizer delocalizes the manufacture of veterinary products of Amboise (Indre and the Loire) to Brazil. 10% of manpower of the factory are threatened. In addition, the research and development center of Tours is closed with 149 layoffs.: France | Les Echos |
| 2007 | -10000 | Internal restructuring: Pfizer cuts 20% of its medical representatives in Europe, closes three research centers in the United States, one in Japan and another one in France, Amboise.: | Les Echos |
| 2006 | -45 | Internal restructuring: Restructuration du laboratoire de R&D d'Amboise.: France | Les Echos |
|
|
|
|
